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61.1  IntroductIon
61.1.1  ClassifiCation, Morphology, and Biology
The genus Stachybotrys is an asexually reproducing, dema-
tiaceous fungus belonging to the mitosporic Hypocreales 
group, order Hypocreales, class Sordariomycetes, subphy-
lum Pezizomycotina, phylum Ascomycota, and kingdom 
Fungi. The mitosporic Hypocreales group encompasses the 
genera of Acremonium, Acrostalagmus, Cephalosporium, 
Chaetopsina, Cylindrocladiella, Escovopsis, Fusarium, 
Gliocladiopsis, Gliocladium, Hobsonia, Illosporium, 
Myrothecium, Parasarcopodium, Polycephalomyces, 
Rotiferophthora, Sesquicillium, Solheimia, Stachybotrys, 
Stilbella, Trichothecium, Tubercularia, Ustilaginoideae, 
Verticillium, and Xenocylindrocladium [1].
In turn, the genus Stachybotrys is divided into 15 recog-
nized species: Stachybotrys bisbyi, Stachybotrys chartarum, 
Stachybotrys chlorohalonata, Stachybotrys cylindrospora, 
Stachybotrys dichroa, Stachybotrys echinata, Stachybotrys 
elegans, Stachybotrys kampalensis, Stachybotrys longis-
pora, Stachybotrys microspora, Stachybotrys nephrospora, 
Stachybotrys oenanthes, Stachybotrys parvispora, 
Stachybotrys subsimplex, and Stachybotrys theobromae, in 
addition to 13 unassigned species. Two species, S. chartarum 
(obsolete synonyms: S. alternans and S. atra) and S. echinata 
(obsolete synonym: Memnionella echinata), are implicated 
in human diseases [2,3].
Stachybotrys spp. grow rapidly and mature in approxi-
mately 4 days. Colonies are “cottony,” white initially and 
turning black with age. Septate hyphae are hyaline first and 
become darkly pigmented later. Conidiophores are simple or 
branched, bearing phialides at apices. Phialides are hyaline 
or pigmented and cylindrical in shape, with swollen upper 
portions, forming clusters of 3–61. Conidia (4.5 × 9 μm) are 
oval, hyaline or pigmented, one-celled, and in clusters.
First identified from a mold growing on domestic wallpa-
per in Prague in 1837, Stachybotrys is a member of the Fungi 
Imperfecti known as “black mold” or “toxic black mold.” 
The fungus is an inhabitant of soil and strata rich in cellu-
lose (e.g., hay, straw, grain, hemp, plant debris, dead roots, 
wood pulp, cotton, fabrics, paper, book bindery glue, plant 
fiber-processing plants, etc.). It has been isolated from con-
taminated grains, tobacco, insulator foams, indoor air, and 
water-damaged buildings. The fungus tolerates temperature 
up to >60°C and survives over winter. Stachybotrys spores 
stay viable for years to decades, and conidia retain viability 
after passage through the gastrointestinal tract. However, the 
organism is killed by composting degradation of manure and 
by disinfectants [4].
Stachybotrys chartarum is a known producer of tricho-
thecene mycotoxins and stachylysin (a hemolysin). The 
best characterized trichothecenes include satratoxins F, G, 
and H, roriden E, verrucarin J, and trichoverrols A and B, 
which share chemical formula of C25H34O6 or C26H38O6 and 
are tricyclic sesquiterpenes with a 12,13-epoxy-trichothec-
9-ene ring. Stachybotrys species also produce spirolactams 
and spirolactones (related to anticomplement components), 
phenylspirodrimanes (inhibitor of complement activation), 
cyclosporins, and endothelin receptor antagonists [5–7].
Trichothecenes modulate inflammatory reactions and 
alter alveolar surfactant phospholipid concentrations, besides 
being potent inhibitors of protein synthesis (e.g., scirpen-
triol, 15-acetoxyscirpendiol, diacetoxyscirpenol (DAS or 
anguidine), verucarin A, and T-2 toxin) and elongation or 
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termination (e.g., trichodermin, trichodermol, crotocol, 
trichothecolone, trichothecin, and verrucarol). They are 
susceptible to destruction by alkali although resistant to 
sunlight, UV light, x-rays, heat (up to 120°C), acids, and 
trichothecenes. The mycotoxins have been isolated from dust 
(e.g., satratoxins, trichoverrols, verrucarol, verrucarins, and 
trichoverrins) and grain (T-2 toxin, nivalenol, and deriva-
tives of others). Humans may develop toxin-related disease 
by ingestion of food products contaminated with the fungus 
and/toxins, exposure to mycotoxins in building (sick-building 
syndrome), and/or inhalation of propogules while undertak-
ing experiments with the fungus [8].
61.1.2  CliniCal features and pathogenesis
61.1.2.1  clinical Features
Stachybotrys may induce disease by (1) infection, (2) genera-
tion of a deleterious immune response, and (3) toxic-irritant 
effects from mold metabolites. Together with other molds (e.g., 
Aspergillus, Penicillium, Alternaria, and Cladosporium), 
Stachybotrys may play a role in the development of sick-
building syndrome [9–25].
Stachybotrys was first noted as a pathogen of horses in 
Ukraine in the early 1930s. After the ingestion of hay con-
taminated with Stachybotrys, horses developed lip edema, 
stomatitis, oral necrosis, rhinitis, conjunctivitis, coagulopa-
thy, hemorrhage, and neurologic disorders (irritability, gait 
disturbance, and blindness). So-called “superinfections” 
occurred and deaths were observed. The disease syndrome 
is referred to as stachybotrytoxicosis. In a rare “atypical” 
or “shocking” form, the disease was primarily neurologi-
cal and highly fatal, with areflexia (loss of sensorimotor 
reflexes), hyperesthesia (hypersensitivity to pain), hyperir-
ritability, blindness, and stupor. Cattle were also affected to 
a lesser extent, and younger animals fared better than older 
one. Similar diseases have been reported in other parts of the 
world. A case of sheep disease was described in the 1990s 
after animals consumed heavily contaminated grain cubes in 
South Africa. The affected animals displayed fever, listless-
ness, oral lesions, pancytopenia, hemorrhage, opportunistic 
infections, and a significant mortality rate [4,26–28].
In areas of enzootic equine stachybotrytoxicosis, fodder 
handlers and others with close contact with musty straw (e.g., 
using straw for fuel or bedding) also developed a dermato-
logic and respiratory syndrome. Dermatologic symptoms 
were dermatitis on the scrotum, medial thighs, axilla, the 
hands, and other areas, which progressed from hyperemia 
to crusting exudates to necrosis, with subsequent resolu-
tion. Some patients showed erosions on the oral and gingival 
mucosa. Respiratory symptoms included catarrhal angina, 
bloody rhinitis, cough, throat pain, chest tightness, and occa-
sional fever. Some patients had transient leukocytopenia 
(reduced white blood cell count) and hemorrhage (bleeding). 
S. chartarum (S. alternans) isolated from straw produced 
areal fructifications in experimental rabbits by a dermal tox-
icity test and similar local and systemic responses on the skin 
of volunteers [4].
Since then, other clinical manifestations have been associ-
ated with exposure to Stachybotrys chartarum mycotoxins 
and spores, ranging from (1) chronic fatigue or headaches, 
(2) fever, (3) irritation to the eyes, mucous membranes of the 
mouth, nose, and throat, (4) sneezing, (5) rashes, (6) chronic 
coughing, (7) nausea, (8) memory loss, (9) vomiting, (10) 
bleeding in the lungs and nose, (11) hypersensitivity pneu-
monitis (HP), (12) allergic rhinitis, and (13) asthma exacer-
bations. Occupants of mold-contaminated, water-damaged 
buildings often develop symptoms in the central nervous 
system (CNS) and the immune system as well as pulmonary 
diseases, allergy, and inflammatory reactions. Occupational 
stachybotrytoxicosis acquired by inhalation showed chest 
and upper airway symptoms, fever, leucopenia, and derma-
titis, which started within 2–3 days of exposure and lasted 
for 3 weeks [18]. In a recent investigation of 32 patients with 
symptoms attributed to mold exposures at work, 25 (88%) 
patients nominated S. chartarum as well as Aspergillus and 
Penicillium. 79%, 70%, and 64% of the 32 patients presented 
with cough, shortness of breath, and chest tightness, respec-
tively, which persisted more than 6 weeks in 91%, sugges-
tive of sick-building syndrome. Thirty one percent of these 
patients had positive skin test to fungal extracts, suggesting 
IgE-mediated or other nonimmune mechanisms could be the 
cause of their symptoms [25,29].
61.1.2.2  Pathogenesis
Contemporary construction methods that use cellulose sub-
strates (e.g., fiber board) favor the growth of cellulolytic fungi 
such as S. chartarum (Meggs [23]). The fungus is shown 
to produce trichothecene mycotoxins as mentioned above, 
although several other fungi (e.g., Fusarium, M. verrucaria, 
M. roridum, Trichothecium, Trichoderma, Cephalosporium, 
Verticimonosporum, and Cylindrocarpon) also synthesize 
these compounds. S. chartarum macrocyclic trichothecene 
mycotoxins (MTM) are dissociated readily from the surface 
of the organism and are consequently spread in damp build-
ings. S. chartarum MTM remain toxic over extended periods 
of time, and individuals with exposure to the fungus contain 
MTM in their sera [24]. High indoor exposures to trichothe-
cene mycotoxins are associated with infrequent ventilation 
or vacuuming of the building, pets, visible mold, and old car-
pets [18].
Trichothecenes are potent translational inhibitors and 
stress kinase activators (Pestka et al. [48]). Experimental 
exposure of trichothecene mycotoxins in mice led to severe 
intra-alveolar, bronchiolar, and interstitial inflammation. 
In experimental Wistar rats, decreased alveolar macro-
phages viability and increased activity of the lysosomal 
enzyme cathepsin D in bronchoalveolar lavage cells after 
S. chartarum exometabolite exposure are noticeable [30]. 
S. chartarum metabolites suppress red blood cell (RBC); 
decrease the total RBC count, hemoglobin, and hematocrit; 
and increase total bronchoalveolar lavage fluid cell count 
(indicating inflammation, lower alveolar macrophage counts, 
and increased granulocyte count related to the BALF cells) 
in these animals [31].
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Satratoxin-positive S. chartarum activates inflamma-
some-associated caspase-1, which is needed for proteolytic 
processing of IL-1beta and IL-18, in human macrophages. 
In addition, purified trichothecene mycotoxins, roridin A, 
verrucarin A, and T-2 toxin activate caspase-1 and strongly 
enhance LPS-dependent secretion of IL-1beta and IL-18. 
Satratoxin-positive S. chartarum and the trichothecenes it 
produces also trigger the activation of caspase-3, which is 
an effector caspase of apoptosis. Thus, human macrophages 
sense trichothecene mycotoxins as a danger signal, which 
activates caspase-1 and further enables the secretion of 
IL-1beta and IL-18 from the LPS-primed cells [32].
Several enzymes from S. chartarum spores demonstrate 
proteolytic activity and are able to hydrolyze gelatin and 
collagen I and IV [33]. S. chartarum spore extracts induce 
high levels of IL-6, IL-8, and TNF-alpha in human tracheal 
epithelial cells. This stimulation of cytokine production is 
abolished by a serine protease inhibitor Pefabloc. Thus, pro-
teinases from S. chartarum spores significantly contribute to 
lung inflammation and injury [34]. S. chartarum spores are 
capable of inducing both apoptosis and necrosis in THP-1 
cells, leading to cell death within 3–6 h. More specifically, 
S. chartarum spores increase the formation of reactive oxy-
gen species (ROS) and oxidative DNA damage. S. chartarum 
trichothecenes T-2 toxin and satratoxin G are mainly respon-
sible for apoptosis [35].
61.1.3  diagnosis
S. chartarum is a cellulose-decaying fungus that grows well 
at room temperature and with humidity above 93%. Isolation 
of S. chatarum requires special media with high concentra-
tion of cellulose and low concentration of sugar and nitro-
gen to compete with Penicillium and Aspergillus. Growing 
S. chatarum isolates on rice or potato dextrose agar results 
in higher proteolytic activity of the spores than those grown 
on drywall.
Thin-layer chromatography, high-performance liq-
uid chromatography (HPLC), tandem mass spectrometry 
(MSMS), gas chromatography (GC), GC combined with 
mass spectrometry (GC-MS, GC-MSMS), and enzyme-
linked immunosorbent assay (ELISA) have been applied to 
detect S. chartarum mycotoxins in mold-affected materials 
inside buildings, in carpet dust from water-damaged build-
ings, and in animal tissues [36–41]. Finally, various reports 
have demonstrated the potential usefulness of molecular bio-
logical techniques for detection of molds in air and clinical 
specimens [42–45].
61.2  Methods
61.2.1  saMple preparation
61.2.1.1  trichothecene collection and Analysis
Airborne trichothecene mycotoxins are collected using a 
SpinCon PAS 450-10 bioaerosol sampler (Sceptor Industries) 
and an Andersen GPS-1 polyurethane foam (PUF) 
high-volume air sampler (Thermo Electron Corporation). 
Entrained solids are concentrated in a phosphate-buffered 
saline (PBS) solution (pH 7.4) to a final volume of 10 mL 
[46].
Following the collection, SpinCon samples (all 10 mL) 
are filtered using Fisher 13 mm-diameter nylon syringe fil-
ters with a 0.45 μm pore size (Fisher Scientific). The filtered 
fluid is transferred asceptically to 15 mL polypropylene coni-
cal centrifuge tubes, frozen at −80°C, and lyophilized using 
a VirTis Freezmobile (SP Industries). The dried samples 
are individually resuspended in 1 mL of pyrogen-free water 
(25°C) for immediate testing.
Filters obtained from the Andersen PUF sampler are 
transferred individually to 50 mL polypropylene centrifuge 
tubes on-site. The filters are suspended in 40 mL of PBS, 
vortexed vigorously for 60 s, removed from the tubes using 
sterile forceps, and then discarded. The PBS extracts are 
filtered into new 50 mL tubes. These are frozen at −80°C, 
lyophilized, and resuspended in 1 mL pyrogen-free water for 
immediate testing.
Samples are analyzed for macrocyclic trichothecenes 
using a QuantiTox kit for trichothecenes (EnviroLogix). This 
competitive ELISA kit incorporates trichothecene-specific 
antibodies immobilized in polystyrene microtiter wells and 
is highly specific for MTM of S. chartarum. To ensure that 
the ELISA ran correctly, the macrocyclic trichothecene rori-
din A is used at a concentration of 50 ng/mL in PBS as a 
positive control for each set of tests. PBS alone is used as a 
negative control [39].
Conidia and other airborne particulates are collected on 
glass microscope slides that have been coated with a thin 
layer of petroleum grease using a foam makeup applicator. 
For testing purposes, conidia are collected from plates that 
have reached confluence (approximately 7–14 days), using 
sterile cotton swabs. To collect the conidia, swabs are gently 
rolled over the surface of the fungal growth. The cotton tips 
of the swabs are placed in 1 mL of sterile room-temperature 
(25°C) PBS in 1.5 mL microcentrifuge tubes and vortexed for 
approximately 1 min to remove conidia. The conidia are then 
counted using a hemacytometer and identified to the genus 
level by a trained technician using an Olympus BH2-RFCA 
optical light microscope. For ELISA testing, the fungal spore 
suspensions are centrifuged at 14,500 rpm for 1 min to pellet 
the conidia. Care is taken not to disturb the conidium pellet, 
and only the top 80% of the supernatant is used for ELISA 
testing. Each sample is run in duplicate wells on two separate 
occasions [39].
61.2.2  deteCtion proCedures
Pounder et al. [45] described a real-time PCR with SYBR 
green DNA-binding dye and amplicon-melting tempera-
ture analysis for fungal detection using pan-fungal primers 
ITS1 forward (5′-TCCGTAGGTGAACCTGCGG-3′) and 
ITS4 reverse (5′-TCCTCCGCTTATTGATATGC-3′). The 
identity of the fungi is verified by subsequent sequencing 
analysis.
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Procedure
 1. The PCR mixture is composed of 1× Lightcycler 
FastStart DNA Master Hybridization Probes mix-
ture (Roche Applied Science) containing deoxy-
nucleoside triphosphates, FastStart Taq DNA 
polymerase, and 1 mM MgCl2 (additional MgCl2 is 
added to a final concentration of 4.6 mM), 0.4 μM 
each of ITS1 forward and ITS4 reverse primers, 1× 
SYBR green (Molecular Probes), and 3 μL template 
DNA.
 2. Thermal cycling parameters are 95°C for 10 min; 50 
cycles of 95°C for 5 s, 60°C for 20 s, and 76°C for 
30 s; and a final extension at 72°C for 2 min.
 3. The quality of the amplicon is determined using the 
derivative of the melt analysis curve (55°C–99°C, 
45-s hold at 55°C, 5 s/°C) using the RotorGene 3000 
(Corbett Robotics, Inc).
 4. The amplified product is purified for bidirectional 
sequencing using ExoSAP-IT (USB Corp). Five 
microliters of Big Dye Terminator Ready Reaction 
Mix v. 1.1 (Applied Biosystems) is added to 4 μL of 
each primer (0.8 pmol/μL) and 3 μL of purified PCR 
product. Cycle sequencing is performed with a 9700 
thermal cycler (ABI), using 25 cycles of 96°C for 
10 s, 50°C for 5 s, and 60°C for 4 min. Sequencing 
reaction products are passed through a Sephadex 
G-50 fine column to remove unincorporated dye ter-
minators. Purified sequencing reaction products are 
run on an ABI Prism 3100 Genetic Analyzer with a 
50 cm capillary array.
 5. Sequences are analyzed with the SmartGene 
Integrated Database Network software version 
3.2.3 vr. SmartGene is a web-based software and 
database system with reference sequences derived 
from the National Center for Biological Information 
(NCBI) GenBank repository.
Note: Sequence-based identifications are defined by per-
cent identity: species, ≥99%; genus, 93%–99%; and 
inconclusive, ≤93%. For strains producing discrepant iden-
tification between the methods based on phenotypic char-
acteristics and ITS sequence analysis, the D1–D2 region of 
the large-subunit rRNA gene is amplified with primers NL1 
(5′-GCATATCAATAAGCGGAGGAAAAG-3′) and NL4 
(5′-GGTCCGTGTTTCAAGACGG-3′) and sequenced for 
species clarification [47].
61.3  conclusIon
The genus Stachybotrys consists of large number of cellu-
lose-decaying fungal species that are distributed in soil, 
plants, air, and water-damaged buildings [48]. These fungi 
produce several mycotoxins that are potent translational 
inhibitors and stress kinase activators, leading to diseases 
in humans. Along with biochemical procedures, molecular 
techniques have been developed to detect the fungus and its 
mycotoxins [49].
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